This reprogrammed metabolism in astrocytes may result from the downregulation of GLUL and GLUD1. These findings suggested abnormalities in glutamate and energy metabolism in astrocytes of AD brains, providing metabolic evidence for further research on the pathogenesis of AD. This evidence concerns the gene GLUD1 and Alzheimer disease.